Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Inhibrx Biosciences, Inc. (INBX)

NASDAQ

$105,70

$--

(0,00%)

Pre-Market

Inhibrx Biosciences, Inc. (INBX) Live Price Chart

Last updated: ⁦2026-09-16 09:04:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Inhibrx Biosciences, Inc. (INBX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $105,70, with a market capitalisation of $1,63B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $26,19 to $155,29. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1,63B
Open	$105,70
Day's High	$155,29
Day's Low	$7,67
Previous Close	$105,61
Volume	101,00
Average Volume	316,35K
P/E Ratio	--
52-Week High	$155,29
52-Week Low	$26,19
Dividend Yield	--
Earnings Date	--

Inhibrx Biosciences, Inc. (INBX) Pre-Market Stock Price

Inhibrx Biosciences, Inc. (INBX) is trading at $105,70 in pre-market trading as of 2026-09-16 08:40:00, up 0,09% ($0,09) from the previous close of $105,61

Pre-market trading shows how investors are pricing INBX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Inhibrx Biosciences, Inc. (INBX) 7-Day Stock Price Change

Over the past seven days, Inhibrx Biosciences, Inc. (INBX) moved from $121,17 to $105,70, representing a decline of 12,77% ($15,47).

The stock traded between $94,00 and $128,54 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 509,63 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

INBX 52-Week Price Position

Position in Range: 61,6%

52W Low$26,19

52W High$155,29

INBX is currently trading at $105,70, placing it 61,6% of the way from its 52-week low of $26,19 to its 52-week high of $155,29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Inhibrx Biosciences, Inc. (INBX)?

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Inhibrx Biosciences, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	110
Exchange	NASDAQ
Company Website	https://www.inhibrx.com

How to Buy Inhibrx Biosciences, Inc. (INBX) Stock on MEXC

Eligible investors can buy real shares of Inhibrx Biosciences, Inc. (INBX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for INBX and Place Your Order

Open the RealStocks trading page and search for INBX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Inhibrx Biosciences, Inc. (INBX) stock price today?

Inhibrx Biosciences, Inc. (INBX) is currently trading at $ 105,70, up 0,09% ($0,09) from the previous close of $ 105,61. Intraday prices update in real time during regular trading hours.

2.Is INBX stock going up or down today?

As of 2026-09-16 08:40:00, INBX is trading at $ 105,70, up 0,09% ($0,09) from its previous close of $ 105,61. The stock has traded between $ 7,67 and $ 155,29 during today’s regular session. Past price movements do not guarantee future results.

3.What is INBX pre-market price?

As of 2026-09-16 08:40:00, INBX is trading at $ 105,70 in pre-market trading, up 0,09% ($0,09) from the previous close of $ 105,61. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is INBX after-hours price?

As of 2026-09-16 08:40:00, INBX is trading at $ 105,70 in after-hours trading, up 0,09% ($0,09) from the regular-session close of $ 105,61. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is INBX stock trading now?

INBX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does INBX sit relative to its 52-week high and low?

Over the past 52 weeks, INBX has traded between a low of $ 26,19 and a high of $ 155,29. At $ 105,70, the stock is positioned 61,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Inhibrx Biosciences, Inc. in?

Inhibrx Biosciences, Inc. (INBX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Inhibrx Biosciences, Inc.'s market capitalisation and where is it listed?

Inhibrx Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1,63B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is INBX valued in terms of P/E ratio and EPS?

INBX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -9,39. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Inhibrx Biosciences, Inc. pay a dividend?

Inhibrx Biosciences, Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.